Company Overview of The Liposome Company, Inc.
As of May 12, 2000, The Liposome Company, Inc. was acquired by Elan Corp. plc. The Liposome Company, Inc. is engaged in the discovery, development, manufacturing, and marketing of proprietary lipid and liposome-based pharmaceuticals, primarily for the treatment of cancer and other related life-threatening illnesses. Its products include drug delivery vehicles and pharmaceuticals utilizing modulated cell signaling and bioactive lipids. The company is based in Princeton, New Jersey.
One Research Way
Princeton Forrestal Center
Princeton, NJ 08540
Key Executives for The Liposome Company, Inc.
The Liposome Company, Inc. does not have any Key Executives recorded.
Similar Private Companies By Industry
|20n Labs, Inc.||United States|
|23andMe, Inc.||United States|
|2C Tech Corporation, Inc.||United States|
|3-V Biosciences, Inc.||United States|
|3D Bio Holdings LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
To contact The Liposome Company, Inc., please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.